Stock 7679 YAKUODO HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials YAKUODO HOLDINGS Co., Ltd.

Equities

7679

JP3931410009

Drug Retailers

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-10 am EDT 		5-day change 1st Jan Change
2,845 JPY 0.00% Intraday chart for YAKUODO HOLDINGS Co., Ltd. +0.49% +4.52%
Apr. 08 Yakuodo's Attributable Profit Up 18% in Fiscal 2024 MT
Apr. 05 YAKUODO HOLDINGS Co., Ltd. Provides Consolidated Earnings Guidance for the First Half 2025 and Full Year Ending February 28, 2025 CI

Valuation

Fiscal Period: February 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 52,746 43,804 50,614 48,008 47,616 55,748 - -
Enterprise Value (EV) 1 59,095 50,254 57,778 59,367 58,085 56,825 55,748 55,748
P/E ratio 17.9 x 14 x 15.4 x 16.2 x 14.7 x 14.9 x 13.6 x 12.7 x
Yield 0.79% 0.99% 0.9% 0.99% 1.03% 0.9% 0.98% 1.05%
Capitalization / Revenue 0.57 x 0.43 x 0.46 x 0.4 x 0.37 x 0.4 x 0.37 x 0.35 x
EV / Revenue 0.57 x 0.43 x 0.46 x 0.4 x 0.37 x 0.4 x 0.37 x 0.35 x
EV / EBITDA 9.03 x 7.14 x 6.88 x 7.24 x 6.38 x 6.61 x 6.19 x 5.81 x
EV / FCF -50.1 x - 66.7 x -16.4 x 23.3 x 15.3 x 20.1 x 16.8 x
FCF Yield -2% - 1.5% -6.11% 4.29% 6.56% 4.97% 5.96%
Price to Book 2.71 x 1.98 x 2.02 x 1.74 x 1.59 x 1.71 x 1.51 x 1.37 x
Nbr of stocks (in thousands) 19,740 19,740 19,740 19,740 19,595 19,595 - -
Reference price 2 2,672 2,219 2,564 2,432 2,430 2,845 2,845 2,845
Announcement Date 4/5/19 4/6/20 4/5/21 4/5/22 4/5/23 4/5/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 91,810 102,017 110,535 120,310 128,791 142,241 149,000 158,000
EBITDA 1 5,844 6,138 7,362 6,634 7,462 8,433 9,000 9,600
EBIT 1 3,886 3,914 4,976 4,043 4,660 5,209 6,100 6,600
Operating Margin 4.23% 3.84% 4.5% 3.36% 3.62% 3.66% 4.09% 4.18%
Earnings before Tax (EBT) 1 4,238 4,312 4,682 4,042 4,722 5,292 6,200 6,700
Net income 1 2,945 3,122 3,290 2,964 3,240 3,825 4,100 4,400
Net margin 3.21% 3.06% 2.98% 2.46% 2.52% 2.69% 2.75% 2.78%
EPS 2 149.2 158.2 166.7 150.2 165.0 195.2 209.2 224.5
Free Cash Flow 1 -1,053 - 759 -2,935 2,042 3,655 2,770 3,320
FCF margin -1.15% - 0.69% -2.44% 1.59% 2.57% 1.86% 2.1%
FCF Conversion (EBITDA) - - 10.31% - 27.37% 43.34% 30.78% 34.58%
FCF Conversion (Net income) - - 23.07% - 63.02% 96.18% 67.56% 75.45%
Dividend per Share 2 21.00 22.00 23.00 24.00 25.00 26.00 28.00 30.00
Announcement Date 4/5/19 4/6/20 4/5/21 4/5/22 4/5/23 4/5/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: February 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 50,831 56,764 31,798 60,302 29,775 30,233 30,952 33,731 64,683 32,119 31,989 33,778 37,764 71,542 35,315 35,384
EBITDA - - - - - - - - - - - - - - - -
EBIT 1 2,035 3,057 1,409 2,647 913 483 1,223 1,599 2,822 1,212 626 1,350 1,919 3,269 1,390 550
Operating Margin 4% 5.39% 4.43% 4.39% 3.07% 1.6% 3.95% 4.74% 4.36% 3.77% 1.96% 4% 5.08% 4.57% 3.94% 1.55%
Earnings before Tax (EBT) 2,246 2,817 - 2,795 1,005 - 1,305 - 2,986 1,320 - 1,441 - 3,358 1,534 -
Net income 1 1,567 1,943 1,175 2,084 712 168 894 1,166 2,060 914 266 984 1,305 2,289 1,062 474
Net margin 3.08% 3.42% 3.7% 3.46% 2.39% 0.56% 2.89% 3.46% 3.18% 2.85% 0.83% 2.91% 3.46% 3.2% 3.01% 1.34%
EPS 79.41 98.47 - 105.6 36.04 - 45.33 - 104.6 46.64 - 50.23 - 116.9 54.20 -
Dividend per Share - - - - - - - - - - - - - - - -
Announcement Date 10/4/19 10/5/20 10/5/21 10/5/21 1/5/22 4/5/22 7/5/22 10/5/22 10/5/22 1/6/23 4/5/23 7/5/23 10/5/23 10/5/23 1/5/24 4/5/24
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: February 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 6,349 6,450 7,164 11,359 10,469 - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 1.086 x 1.051 x 0.9731 x 1.712 x 1.403 x - - -
Free Cash Flow 1 -1,053 - 759 -2,935 2,042 3,655 2,770 3,320
ROE (net income / shareholders' equity) 16.2% 14.1% 13.9% 11.3% 11.3% 12.1% 11.7% 11.3%
ROA (Net income/ Total Assets) 7.71% 6.84% 9.57% 7.15% 7.72% 8.12% 8.8% 9%
Assets 1 38,216 45,613 34,376 41,463 41,979 47,088 46,591 48,889
Book Value Per Share 2 986.0 1,123 1,268 1,395 1,528 1,700 1,883 2,082
Cash Flow per Share 248.0 271.0 288.0 281.0 308.0 339.0 - -
Capex 1 4,836 4,865 4,255 6,017 4,364 3,000 4,000 4,000
Capex / Sales 5.27% 4.77% 3.85% 5% 3.39% 2.11% 2.68% 2.53%
Announcement Date 4/5/19 4/6/20 4/5/21 4/5/22 4/5/23 4/5/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for YAKUODO HOLDINGS Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs with Grocery

1st Jan change Capi.
YAKUODO HOLDINGS CO., LTD. Stock YAKUODO HOLDINGS Co., Ltd.
+4.52% 358M
COSMOS PHARMACEUTICAL CORPORATION Stock COSMOS Pharmaceutical Corporation
-16.15% 3.47B
SUNDRUG CO.,LTD. Stock Sundrug Co.,Ltd.
-5.36% 3.22B
TSURUHA HOLDINGS INC. Stock Tsuruha Holdings Inc.
-22.81% 3.11B
SUGI HOLDINGS CO.,LTD. Stock Sugi Holdings Co.,Ltd.
+7.98% 2.71B
KUSURI NO AOKI HOLDINGS CO., LTD. Stock Kusuri No Aoki Holdings Co., Ltd.
-9.42% 1.76B
CREATE SD HOLDINGS CO., LTD. Stock Create SD Holdings Co., Ltd.
+12.23% 1.41B
GREAT TREE PHARMACY CO., LTD. Stock Great Tree Pharmacy Co., Ltd.
-17.17% 1B
SHUYU CIVILIAN PHARMACY CORP., LTD. Stock ShuYu Civilian Pharmacy Corp., Ltd.
-36.81% 724M
FARMACIAS BENAVIDES, S.A.B. DE C.V. Stock Farmacias Benavides, S.A.B. de C.V.
-0.53% 461M
Retail - Drugs with Grocery
  1. Stock Market
  2. Equities
  3. 7679 Stock
  4. Financials YAKUODO HOLDINGS Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW